Filing Details
- Accession Number:
- 0001562180-20-000118
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-03 16:01:35
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-03 16:01:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1690585 | Magenta Therapeutics Inc. | MGTA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1741286 | Jason Gardner | C/O Magenta Therapeutics, Inc. 100 Technology Square Cambridge MA 02139 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-01-02 | 2,800 | $15.10 | 262,412 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 292,990 | Indirect | By J.P. Gardner Irrevocable Trust |
Common Stock | 359,092 | Indirect | By P.S. Gardner Irrevocable Trust |
Footnotes
- This trade is pursuant to an active 10b5-1 plan.